Bristol-Myers Squibb Co. BMY shares are trading higher on Wednesday as the company is announcing a strategic agreement with ...

The integration helps researchers understand disease biology and uncover biomarkers for developing new medicines.

Scientists at Bowling Green State University recently made a series of discoveries that could have wide-ranging implications ...

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...

Incyte (Nasdaq:INCY) and Genesis Molecular AI today announced a significant expansion of their strategic colla ...

May 20 (Reuters) - Bristol Myers Squibb said on Wednesday it is partnering with Anthropic to make its Claude AI model available to over 30,000 employees in an effort to accelerate the discovery, ...

Researchers developing autonomous artificial intelligence research tools say that they’ll soon be able to integrate with lab ...

Other venture-backed companies like Chai Discovery and Isomorphic Labs have raced to build better models. SandboxAQ is ...

Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it ...

When Daniel Haders, Ph.D., was working in venture capital, he was on the hunt for an AI-driven drug discovery company that ...

Traditionally, developing a new drug takes many years and requires a massive financial investment, often involving significant risk and a high likelihood of failure. AI models trained on extensive ...

Bristol Myers Squibb released a significant announcement on Wednesday that it is collaborating with Anthropic to make its ...